Products
Valnemulin is commercially available as a drug premix. It has been approved in many countries since 2002.
Structure and properties
Valnemulin (C31H52N2O5S, Mr = 564.8 g/mol)
Effects
Valnemulin (ATCvet QJ01XQ02) has antibacterial properties. The effects are based on inhibition of bacterial protein synthesis.
Indications
Treatment and prevention of swine dysentery.